Diagnostic Labs Rapidly Expand Testing Capacity
Diagnostic and medical testing laboratories pursuing testing volume capacity and sample integrity are increasingly specifying validated PS containers with documented clarity and seal integrity testing, rather than the conventional unvalidated container that dominated diagnostic packaging when PS molding costs were less competitive in prior years. This shift commands meaningfully higher unit cost than conventional unvalidated format given the enhanced testing and certification requirements involved. Converters report validated orders now outpacing unvalidated orders across several major diagnostic laboratory accounts tracked this cycle, a clear reversal from just a few years earlier across comparable launches. That demand is tracked in the medical containers market, which MMA expects to expand at 7.6% a year to USD 12.1 billion by 2036.
Market Impact: Drives roughly 4% of demand








